US Patent Issued to Amgen on Oct. 7 for "Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists" (California Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,149, issued on Oct. 7, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists" was invented by Darren L Bates (Oak Park, Calif.), Donghui Shi (Thousand Oaks, Calif.), David J. Lloyd (Thousand Oaks, Calif.), Pavel Bondarenko (Thousand Oaks, Calif.), Mark L Michaels (Encino, Calif.), Todd Hager (Agoura Hills, Calif.), Xiaoshan Min (Burlingame, Calif.), Aiko Umeda (Woodland Hills, Calif.), Irwin Chen (Los Angeles) and Zhulun Wang (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Met...